article_snippet: When a copy of the HIV virus sneaks into a human cell, a copy of the HIV virus can cause havoc.
article_snippet: a copy of the HIV virus takes control of a human cell's own molecular machinery to made copies of the virus's genetic material and then buries copies of the virus's genetic material in the cell's own genes.
article_snippet: From there, a human cell becomes an HIV factory, making new copies of the virus to spread throughout the body.
article_snippet: Existing HIV drugs target individual steps of this lifecycle; some stop the virus from integrating into cells' DNA, for instance, while others try to stop the affected cells from producing more virus.
article_snippet: The problem with Existing HIV drugs, explains Hsin-Kai Liao, a research associate in the Izpisua Belmonte lab, is that Hsin-Kai Liao, a research associate in the Izpisua Belmonte lab don't actually remove the copies of the virus that are hidden within cells' DNA.
article_snippet: the copies of the virus that are hidden within cells' DNA can remain dormant for years and then activate again. '
article_snippet: Patients normally need to take drugs every day or every week for Patients whole lives, because of the HIV that can be latent,' says Professor Liao. '
article_snippet: The new Salk study showed that the method is effective against active, full-length HIV rather than a shortened, inactive version of the virus.
article_snippet: the virus can mutate very quickly,' says Liao. '
article_snippet: If we target multiple regions at the same time, we reduce the chance that the virus can develop resistance.'